Patterns of gene promoter methylation in squamous cell cancer of the head and neck
- PMID: 12082610
- DOI: 10.1038/sj.onc.1205528
Patterns of gene promoter methylation in squamous cell cancer of the head and neck
Abstract
Promoter methylation is an important pathway in transcriptional silencing of known and candidate tumor suppressor genes in Head and Neck Squamous Cell Carcinoma (HNSCC). In order to study the association of tumor suppressor gene promoter methylation in HNSCC with patient clinical characteristics, especially alcohol consumption and tobacco smoking, we examined promoter methylation of the p16(INK4a), DAP-kinase, E-Cadherin, and RASSF1A genes using methylation-specific PCR (MSP) in 80 patients. The prevalence of p16(INK4a), DAP-kinase, E-Cadherin, and RASSF1A promoter methylation was 26/80 (32.5%), 19/80 (23.8%), 29/80 (36.3%), 6/80 (7.5%) respectively. In 48 cases (60%), at least one of these promoters was methylated. There was a significant association of methylation of any of these genes and ever smoking (P=0.006). p16(INK4a) gene promoter methylation was associated with a younger age of smoking initiation (P<0.03); E-Cadherin promoter methylation was associated with an increased number of pack years smoked (P<0.03). We also found an association of methylation of any gene and T status (OR=2.7, P<0.05). Tumors with p16(INK4a) methylation were significantly less likely to show lymph node metastasis (P<0.001). DAP-kinase promoter methylation was significantly associated with lymph node metastasis and this relationship was dependent upon p16(INK4a) promoter methylation status. Our results suggest that, in HNSCC, promoter methylation of these four genes accumulates with increasing tumor size. This may reflect distinct pathways of somatic inactivation leading to cancer; additional larger studies are needed to further investigate this possibility. Tobacco smoking may play an important role in both the occurrence of promoter methylation as well as delineating the precise pathway that eventually results in a tumorigenic phenotype.
Similar articles
-
The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.Mod Pathol. 2003 Sep;16(9):944-50. doi: 10.1097/01.MP.0000085760.74313.DD. Mod Pathol. 2003. PMID: 13679459
-
p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.Cancer Res. 2001 Apr 15;61(8):3419-24. Cancer Res. 2001. PMID: 11309302
-
Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.Cancer Res. 2002 Apr 15;62(8):2370-7. Cancer Res. 2002. PMID: 11956099
-
[Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].Rinsho Byori. 2001 Dec;49(12):1242-7. Rinsho Byori. 2001. PMID: 11797395 Review. Japanese.
-
p16(MTS-1/CDKN2/INK4a) in cancer progression.Exp Cell Res. 2001 Mar 10;264(1):42-55. doi: 10.1006/excr.2000.5149. Exp Cell Res. 2001. PMID: 11237522 Review.
Cited by
-
Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients.Mol Biol Rep. 2010 Jan;37(1):325-32. doi: 10.1007/s11033-009-9731-z. Epub 2009 Aug 19. Mol Biol Rep. 2010. PMID: 19690981
-
An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.Cancer Med. 2021 Sep;10(17):5936-5947. doi: 10.1002/cam4.4142. Epub 2021 Jul 27. Cancer Med. 2021. PMID: 34313009 Free PMC article.
-
Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer.J Carcinog Mutagen. 2013 Aug 5;Suppl 7:4. doi: 10.4172/2157-2518.S7-004. J Carcinog Mutagen. 2013. PMID: 25587491 Free PMC article.
-
Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma.Cancer Sci. 2006 Oct;97(10):1070-4. doi: 10.1111/j.1349-7006.2006.00283.x. Cancer Sci. 2006. PMID: 16918994 Free PMC article.
-
Analysis of salivary detection of P16INK4A and RASSF1A promoter gene methylation and its association with oral squamous cell carcinoma in a Colombian population.J Clin Exp Dent. 2020 May 1;12(5):e452-e460. doi: 10.4317/jced.56647. eCollection 2020 May. J Clin Exp Dent. 2020. PMID: 32509227 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials